Object. The aims of this study were to determine whether contrast-enhanced ultrasonography (CEU) could be used for noninvasive evaluation of cerebral perfusion in patients with traumatic brain injury (TBI) and to assess the effect of decompressive surgery on cerebral perfusion as measured by CEU.
RAUMATIC brain injury is divided into primary injury, which occurs at the time of the trauma, and secondary injury or sequelae, including ischemia, cerebral edema, and mass effects from hematoma. It is the secondary insults that modern neurosurgical care is intended to minimize. The detection and prevention of secondary ischemic injury after TBI is currently dependent on measurement and optimization of ICP 12, 17 and CPP. 18, 23 More recent monitoring techniques include measurement of jugular bulb O 2 saturation 3,4 and brain O 2 and metabolite content, 9, 10, 24, 32, 33 with a view toward the detection and prevention of inadequate CBF and oxygenation. However, these surrogate indices do not directly measure cerebral microvascular blood flow. Although techniques for spatially assessing CBF have been developed for CT and magnetic resonance imaging, they are expensive and complex and are not portable. A noninvasive method for spatially assessing cerebral microvascular blood flow at the bedside would be valuable for monitoring patients, guiding treatment, and evaluating response to therapy.
Contrast-enhanced ultrasonography is a noninvasive perfusion imaging technique that has been used to evaluate microvascular perfusion in the heart, 28 skeletal muscle, 5 and kidneys. 29, 30 This technique relies on ultrasonic detection of intravenously injected gas-filled encapsulated microbubble contrast agents that possess microvascular rheological characteristics similar to those of RBCs. 16 To assess perfusion, microbubbles are infused intravenously and reach a steady state within the microcirculation. Microbubbles are then destroyed by a high-power ultrasonographic pulse and the subsequent rate and extent of microbubble replenishment are used to determine microvascular blood velocity and volume, respectively. 28 Contrast-enhanced ultrasonography has been used to assess microvascular blood flow in Contrast ultrasonographic assessment of cerebral perfusion in patients undergoing decompressive craniectomy for traumatic brain injury the brain, 8, 14, 22, 25 and perfusion imaging correlates well with blood flow measurements made by radiolabeled microspheres in animal models. 22 In this study, we hypothesized that CEU could be used for noninvasive evaluation of cerebral perfusion in patients with TBI and to assess CBF response to therapy. To test our hypothesis, we measured acute changes in microvascular perfusion produced by 1) decompressive craniectomy; and 2) alteration of ICP and CPP from positional changes. A secondary aim was to study whether CEU could be used spatially to assess abnormalities in cerebral perfusion produced by contusion and parenchymal hemorrhage.
Clinical Material and Methods

Study Population
This study was approved by both the United States Food and Drug Administration (investigational new drug 69,338) and the Human Investigation Committee at the University of Virginia. Surrogate informed consent was obtained for all patients. Six patients with TBI who were undergoing decompressive craniectomy were included in the study. The enrollment criteria included evidence of TBI on a CT scan, Glasgow Coma Scale score less than 8, and elevated ICP measured by intraparenchymal pressure monitor. Standard neurotrauma care in compliance with the recommendations of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury 1 was initiated at admission. In brief, the standard care included intubation and mechanical ventilation with normocapnia or mild hypocapnia (PCO 2 35-40 mm Hg), sedation and chemical paralysis (using propofol, midazolam, and fentanyl), and maintenance of normothermia. As a general institutional practice, decompressive craniectomy is performed after mannitol (1-g/kg bolus administered intravenously) has failed to control ICP. All enrolled patients had unsuccessful medical ICP management (persistent elevation of ICP Ͼ 20 mm Hg) and underwent surgery for decompressive craniectomy according to institutional practice. Depending on the pattern of edema or presence of underlying hematoma, either unilateral hemicraniectomy or bifrontal decompressive craniectomy as described by Kjellberg and Prieto 16 was performed.
Contrast-Enhanced Ultrasonography
Contrast-enhanced ultrasonography was performed using power-modulation imaging (SONOS 5500; Philips Medical Systems, Bothell, WA), a low-power imaging method that optimizes microbubble signal-to-noise ratio and is nondestructive of microbubble agents. Imaging was performed at a transmission frequency of 1.7 MHz, a mechanical index of 0.2 (Ϫ17 to Ϫ18 dB), and a pulse-repetition frequency of 2.7 to 2.9 kHz. Background gray-scale was suppressed except at specular borders, and power-gain was optimized and held constant for each patient. Imaging was performed in the sagittal and coronal planes through a bur hole for the initial precraniectomy study and through the calvarial defect at the same site as the bur hole for subsequent studies. For contrast enhancement, a suspension composed of lipidshelled octafluoropropane microbubbles (Definity; BristolMyers Squibb Medical Imaging, Inc., North Billerica, MA) suspended in normal saline solution was infused intravenously at a rate of 0.1 ml/minute. Images were acquired for at least 10 seconds after a two-frame high-power (mechanical index = 0.7) destructive pulse sequence.
Images were analyzed offline. The method used to assess microvascular perfusion is schematically illustrated in Fig.  1 . The frame obtained immediately after destruction was selected as background to eliminate signal from large vessels with high-velocity flow. 5 This frame was digitally subtracted from subsequent frames at 1-second intervals. Video intensity was measured from a region of interest placed over the entire brain parenchyma within the field of view, avoiding regions of visually apparent acoustic shadowing. Time versus VI data were fit to the following function: y = A(1Ϫ e Ϫ␤t ), where y is VI at time t, A is the plateau VI reflecting relative microvascular blood volume, and ␤ is the rate constant reflecting the rate of rise of VI or mean RBC velocity. 28 When examining regional perfusion related to hemorrhagic contusions, data were generated from the central nonenhancing core and three concentric regions at 1-cm increments. For comparison, a reference control region located in the contralateral hemisphere at a similar imaging depth was selected from the same imaging plane.
Study Protocol
Baseline CEU measurements were made in the operating room. Mean arterial blood pressure was measured by an arterial catheter, and ICP relative to the foramen of Monro was measured with an intraparenchymal pressure monitor. Cerebral perfusion pressure was determined by subtracting the ICP from the mean arterial pressure. Arterial blood was sampled for measurement of PCO 2 . Contrast-enhanced ultrasonography was performed by imaging through the initial single bur hole placed at the Kocher point before craniectomy. All measurements were repeated in the operating room immediately after decompressive craniectomy and on the 1st and 2nd postoperative days, with the probe placed at the same location over the Kocher point. On the postoperative days, studies were performed with the patient in the recumbent position and with the head elevated 35˚, in random order. Perfusion imaging of both the ipsilateral hemisphere and the contralateral hemisphere can be performed from a single bur hole by changing the depth of ultrasonographic measurement.
Statistical Analysis
Data were analyzed in RS/1 (Domain Manufacturing Corp., Burlington, MA) and expressed as means Ϯ standard deviations unless stated otherwise. Comparisons between stages were made using repeated-measures analysis of variance. Individual comparisons according to patient position were performed using paired Student t-tests. Correlations were performed using least-squares fit regression analysis or the Spearman rank correlation. Differences were considered significant at a probability value less than 0.05 (twosided).
Results
Demographic and Clinical Data
The clinical data for the patients enrolled in the study are shown in Table 1 . The study population included five fe-male patients and one male patient, with a median age of 27 years (range 17-50 years). The mean time from trauma to surgery was 11 Ϯ 6 hours (median 9 hours). All patients except one were involved in a motor vehicle accident. Neurological status improved rapidly in four patients, all of whom were able to follow verbal commands by Day 3 after decompressive craniectomy, and improved more slowly in one other patient. In the remaining patient neurological status remained poor by Day 3 postinjury, and the patient died after supportive care was withdrawn.
Effect of Decompressive Craniectomy on Cerebral Perfusion
Mean arterial blood pressure, ICP, CPP, and PCO 2 measurements immediately before, immediately after, and on postoperative Days 1 and 2 after decompressive craniectomy are shown in Table 2 . Craniectomy produced an acute decrease in ICP of approximately 20 mm Hg that persisted over the first 2 postoperative days. The drop in ICP resulted in an increase in the CPP acutely after craniectomy. The patients were mildly hypocapnic in the operating room as a result of hyperventilation deemed necessary for treatment of elevated ICP before craniectomy.
Decompressive craniectomy resulted in an acute threefold improvement in cerebral microvascular blood flow measured by CEU, due largely to an improvement in microvascular blood volume (Fig. 2) . Microvascular blood flow and volume further improved by almost twofold between the immediate postcraniectomy study and postoperative Day 1, without subsequent change on Day 2. Contrastenhanced ultrasonography images demonstrating sequential improvement in cerebral perfusion after decompressive craniectomy are shown in Fig. 3 . In this example, there was a marked, acute improvement in perfusion immediately after craniectomy. Most of the improvement occurred because of an increase in microvascular blood volume, indicated by an increase in the plateau VI obtained after complete contrast replenishment of the sector. Although the study was not A continuous intravenous infusion of microbubble contrast agent is used to achieve a steady-state concentration in the blood pool. A brief high-power ultrasonography sequence results in destruction of all microbubbles within the imaging sector and reduction in contrast enhancement to background levels. Subsequent imaging at low power (nondestructive for microbubbles) is used to evaluate the rate and extent of replenishment of microbubbles back into the microcirculation (see text for mathematical modeling), which reflects microvascular blood velocity and volume, respectively, the product of which represents blood flow. Using frames obtained 1 second after destruction as background (BG) for digital subtraction eliminates unwanted data from large vessels.
powered to explore the prognostic value of CEU, the one patient who did not experience neurological recovery had the lowest value of perfusion evaluated with CEU on postoperative Day 2, despite having an ICP less than 10 mm Hg.
No relation was found between the absolute value of microvascular blood flow evaluated with CEU and the absolute ICP (r = 0.02, p = 0.61). There was, however, a significant inverse relation between the change in ICP and the change in microvascular blood flow after craniectomy (Fig.  4 left) . This seemingly paradoxical relationship indicated that flow recovery was less likely when preoperative ICP was extremely elevated, a concept that is further supported by the significant negative relation between the initial ICP and subsequent change in microvascular blood flow (Fig. 4  right) . No significant relation was found between CPP and any blood flow parameters. There was no relation between the injury severity score and any of the perfusion parameters.
Influence of Position on Microvascular Perfusion
Head-of-bed elevation to an incline of 35˚ was performed on postoperative Days 1 and 2. Data from both days were grouped for analysis. Compared with the recumbent position, head-of-bed elevation produced a small but significant decrease in ICP and a substantial (Ͼ 30%) increase in microvascular blood flow measured by CEU. Cerebral perfusion pressure did not significantly change with position (Table 3) .
Spatial Assessment of Perfusion in Patients With Hematoma
A discrete parenchymal hematoma was identified on the CT scans of the head in three patients. Figure 5 shows an example of hypoperfusion in the region of a hematoma with incrementally greater perfusion with increasing distance from the central core. In all three patients with hematoma, microvascular blood flow was essentially absent in the region of the hematoma and increased with radial distance from the hematoma (Fig. 6) . Microvascular blood flow in tissue immediately adjacent to the hematoma tended to be lower than in normal tissue, consistent with mass effect and compression of vasculature, whereas flow adjacent to this area tended to be greater than in normal tissue further removed, consistent with hyperemia of the border zone.
Discussion
A method capable of accurately assessing cerebral microvascular blood flow in the operating room or at the bedside would be valuable in the treatment of patients with TBI. Such a technique could be used to determine severity of hypoperfusion, to evaluate adequacy of interventions to improve microvascular blood flow, to monitor for second- ary ischemic injury, and possibly to determine prognosis. Although ICP and CPP measurements provide prognostic value in patients with TBI, 12,17,18 they do not directly measure temporal changes in CBF that occur during secondary injury, thereby limiting somewhat their utility in the detection of inadequate cerebral perfusion. Accordingly, it has been suggested that individualized management in each case should be based not only on ICP and CT findings but also on serial assessment of regional 19 and global CBF. 18 Although methods for evaluating cerebral perfusion have been put into clinical use in contemporary neurosurgical practice, most have substantial limitations. Methods that rely on CT, magnetic resonance, and PET imaging are expensive, require patient transport with its attendant risks, and are poorly suited for intraoperative applications and frequent monitoring. Measurement of Xe clearance, thermal diffusion, and arteriovenous nitrous oxide gradients can be performed at the bedside, 15, 21 but these methods are limited in assessment of the entire brain or regional perfusion abnormalities. 2 Transcranial Doppler ultrasonography can be used to evaluate the status of large vessels but not microvascular flow.
In this pilot study, we have demonstrated that CEU can be used temporally and spatially to assess cerebral perfusion in patients with severe TBI. Contrast-enhanced ultrasonography was used to quantify changes in blood flow produced by decompressive craniectomy, to assess blood flow alterations related to patient position and ICP, and to evaluate spatial heterogeneity of flow produced by parenchymal hematoma. This noninvasive imaging technique has several practical advantages, making it ideal for clinical application. It is portable, relatively inexpensive, and provides information almost immediately to the clinician. It is also rapid, requiring approximately 5 minutes to perform, and therefore can be used to assess perfusion with high temporal resolution and evaluate the effects of an acute intervention. Contrast-enhanced ultrasonography also provides a direct measure of microvascular blood flow independent of vascular permeability owing to the use of microbubble contrast agents that are not diffusible and that have microvascular behavior similar to that of RBCs. 16 In the current study, quantitative techniques were used that were originally developed to assess myocardial perfusion 28 and have been validated for quantifying cerebral perfusion. 22 This method allows for the separate evaluation of microvascular blood volume and velocity and has been applied to assess stroke-related regional cerebral perfusion abnormalities using transtemporal bone windows 8, 14 and to assess flow abnormalities associated with gliomas in animal models. 6 The image analysis protocols used to assess relative capillary perfusion and its components have been validated in comparison with analyses using radiolabeled microspheres and capillary xanthine oxidase activity in animal studies and in comparison with PET imaging in patients. 5, 23, 27, 29 In this study, CEU was performed in patients with severe TBI undergoing emergent decompressive craniectomy for evidence of persistently elevated ICP, most of whom also had evidence of high-risk features on CT scans, such as cisternal effacement, midline shift, intracerebral hemorrhage, or subarachnoid hemorrhage. Previous studies using CT perfusion imaging have demonstrated that surgical intervention can substantially improve CBF in these patients. 31 Using CEU, we were able to determine that microvascular blood flow increased an average of fivefold over the 3-day study period. The ability to perform CEU in the operating suite, minutes before and after craniectomy, allowed assessment of the immediate effects of decompres-
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Contrast ultrasonography assessment of cerebral perfusion sion on CBF. Blood flow increased by an average of threefold immediately after craniectomy and then improved further over the ensuing 24 hours. Parametric assessment of CEU data revealed that the major effect of craniectomy was to increase microvascular blood volume. This finding indicates that decompression produces an immediate increase in the number of perfused capillaries or microcirculatory units.
743
Similar to other studies, 7 we found that cerebral perfusion correlated poorly with absolute ICP, underscoring the need for noninvasive methods for routine monitoring of perfusion. However, there was a significant negative correlation between the initial ICP before decompressive craniectomy and subsequent recovery of perfusion. This finding argues against the notion that patients with the highest ICP have the most to gain by therapy aimed at restoring perfusion. It does, however, support the idea that patients with the highest initial ICP have the greatest degree of primary injury, the greatest amount of irreversible microvascular damage, and the worst prognosis. 12 Although the study was underpowered for assessment of long-term outcomes, it is interesting to note that microvascular blood flow evaluated by CEU was lowest in the one patient in whom neurological deterioration continued after surgical intervention.
Head-of-bed elevation is commonly practiced in patients with TBI to decrease venous outflow pressure and reduce ICP in part due to displacement of cerebrospinal fluid into the spinal subarachnoid space. 13 Some clinicians have advocated that this maneuver can compromise cerebral perfusion by producing arterial hypotension. We determined that head-of-bed elevation improved cerebral microvascular blood flow by more than 30%. Unlike decompressive craniectomy, head-of-bed elevation augmented blood flow primarily through an increase in microvascular blood velocity. This finding suggests that head-of-bed elevation optimizes transcapillary pressure gradients by reducing venous pressure 11 and serves to explain why changes in microvascular blood flow were proportionally greater than changes in ICP.
Regional assessment of perfusion is also an important consideration in patients with parenchymal hematoma. Studies using CT or PET imaging have demonstrated markedly reduced perfusion at the central core of a focal contusion with gradual improvement with radial distance from the center. 20, 26 Contrast-enhanced ultrasonography performed in the current study revealed a similar pattern of abnormal perfusion and a peripheral rim of relative hyperemia. We believe that the ability to serially assess perfusion with CEU could be valuable for characterizing how regional flow abnormalities associated with contusion are affected by interventions aimed at improving global flow and ICP.
There are several limitations of this study. First, a small number of patients were enrolled, although we believe that our results justify a larger and more comprehensive study. Second, imaging was performed through a craniectomy defect or bur hole. We did not test the ability to image through a temporal or other bone window because our aim was to keep the acoustic power as low as possible given the paucity of information on safety of cerebral CEU using highpower imaging. Third, we did not include a control group with a similar degree of TBI who did not undergo craniectomy, because ultimate determination of the most appropriate therapy was not the primary aim of the study. Another technical limitation is that relative perfusion rather than absolute perfusion was measured. Although a constant infusion rate for contrast was used for each patient, differences in microbubble volume of distribution or clearance rate at the different study intervals may have influenced the measurement of microvascular blood volume. Additional nonstandard monitoring techniques were not used to validate CEU, but future studies will likely include such comparisons.
Conclusions
Contrast-enhanced ultrasonography can be used at the bedside to assess cerebral perfusion in patients with TBI. The technique has many advantages, including portability, capacity for rapid data acquisition, and widespread availability of imaging hardware. Our results indicate that changes in CBF that occur immediately after decompressive craniectomy or secondary to positional changes can be detected by CEU and that CEU is sensitive enough to detect regional changes in blood flow in the traumatized brain. Larger studies evaluating whether information provided by CEU can be used to guide therapy or to predict long-term outcomes will be needed to establish the role of this technique in contemporary neurosurgical care. 
